Epicur Pharma® brings a unique advantage to the veterinary industry. The 503B facility manufactures drugs with consistent potency, sterility, and purity from batch to batch.
A division of Stokes Healthcare and a sister company of Stokes Pharmacy, Epicur® was developed in 2016 to align with the Food and Drug Administration’s (FDA) recommended guidelines and requirements for producing high-quality manufactured drugs. The 503B standards put in place reflect current Good Manufacturing Practices (cGMP), the same regulations in place for human pharmaceuticals.
Epicur Pharma® is proud to be a pioneer in animal drug standards, offering one of the largest selections of manufactured drugs that are traditionally compounded. Our commitment to drug consistency and quality emphasizes our devotion to patient safety.
Our 503B manufactured products have key advantages for veterinarians and patients:
*does not apply to all products
Did you know? When purchasing from an FDA Registered 503B Outsourcing Facility, dispensing and unlimited hospital administration is permitted*.
*Varies based on individual state law. Federal law allows dispensing and administration – FDA Federal SEC. 503B. [21 U.S.C. 353b]
The map shows the states where Epicur Pharma® is currently licensed as an outsourcing facility, as well as pending activity.
Get a glimpse of the quality processes that ensure every batch of your B products gets our A game.
Have questions about compounded control drugs for office use? Our team answered common questions we hear!
Get more details about Epicur’s 503B manufactured products and how they can make a difference in patient outcomes.